Literature DB >> 16682837

A follow-up of GH-dependent biomarkers during a 6-month period of the sporting season of male and female athletes.

A Sartorio1, M Jubeau, F Agosti, N Marazzi, A Rigamonti, E E Müller, N A Maffiuletti.   

Abstract

In order to verify the effects of the sporting season (entailing periods of training, competition, recovery, resting) on GH-dependent parameters in male and female athletes from different sporting disciplines, 47 male and female athletes (3 rowers, 5 swimmers, 7 alpine skiers, 3 soccer players, 7 middle distance runners, 14 sprinters, 4 triathletes, 1 road walker, 3 cyclists) were followed-up for a period of 6 months. Blood samples were taken every two months for the evaluation of IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP). Abnormal IGF-I, PIIINP and ICTP levels were observed during the follow-up period in 7/100 (7%), 9/100 (9.0%) and 8/100 (8%) samples of the male group, respectively, and in 9/88 (10.2%), 1/88 (1.1%) and 0/88 (0%) samples of the female group, respectively. Abnormal levels appeared to be randomly distributed over the different periods of the sporting season and within male and female subjects, with the large majority of abnormal values being found in the younger athletes. Taking into account all the tests done during the 6-month period (no. 564), individual markers falling outside the normal range (for age) were observed in a small number of instances (34/564 tests done, 24/300 for males and 10/264 for females). When our method for the detection of exogenous recombinant GH (rhGH) administration, based on the concomitant determination of these three peripheral GH-dependent markers and on the attribution of specific scores, was applied in the same athlete at a given time point of the 6-month period, the prevalence of a positive score was extremely low (ie, 3/188 samples or 1.6%). Total positive scores were actually recorded in only three male athletes (2 swimmers and 1 skier, aged <21 yr) at one occasion during the 6-month period considered. In contrast, no total positive scores were found in female athletes (ie, 0/88 samples). In conclusion, the concentrations of IGF-I, PIIINP and ICTP were stable and not significantly modified during 6 months of a sporting season (entailing periods of training, competition, recovery, resting) in athletes from different sporting disciplines. Therefore our method, based on the concomitant determination of three peripheral GH-dependent biomarkers appears safe, acceptable, relatively inexpensive and repeatable (in case of positive or suspected values) immediately or at different intervals of the sporting season. Further additional studies are requested to precise the cut-off values for narrower age-class subdivisions in both genders in order to improve the proposed method.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682837     DOI: 10.1007/BF03345546

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

Review 1.  Growth hormone and exercise.

Authors:  P J Jenkins
Journal:  Clin Endocrinol (Oxf)       Date:  1999-06       Impact factor: 3.478

Review 2.  Test method: GH.

Authors:  M Bidlingmaier; Z Wu; C J Strasburger
Journal:  Baillieres Best Pract Res Clin Endocrinol Metab       Date:  2000-03

Review 3.  Neuroendocrine control of growth hormone secretion.

Authors:  E E Müller; V Locatelli; D Cocchi
Journal:  Physiol Rev       Date:  1999-04       Impact factor: 37.312

4.  Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on-the-field.

Authors:  A Sartorio; N Marazzi; F Agosti; G Faglia; C Corradini; E De Palo; S Cella; A Rigamonti; E E Muller
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

5.  Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary report.

Authors:  Alessandro Sartorio; Fiorenza Agosti; Nicoletta Marazzi; Nicola A Maffiuletti; Silvano G Cella; Antonello E Rigamonti; Laura Guidetti; Luigi Di Luigi; Eugenio E Muller
Journal:  Clin Endocrinol (Oxf)       Date:  2004-10       Impact factor: 3.478

6.  Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males.

Authors:  J D Wallace; R C Cuneo; P A Lundberg; T Rosén; J O Jørgensen; S Longobardi; N Keay; L Sacca; J S Christiansen; B A Bengtsson; P H Sönksen
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

7.  Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.

Authors:  S Longobardi; N Keay; C Ehrnborg; A Cittadini; T Rosén; R Dall; M A Boroujerdi; E E Bassett; M L Healy; C Pentecost; J D Wallace; J Powrie; J O Jørgensen; L Saccà
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

Review 8.  Growth hormone abuse: methods of detection.

Authors:  Antonello E Rigamonti; Silvano G Cella; Nicoletta Marazzi; Luigi Di Luigi; Alessandro Sartorio; Eugenio E Müller
Journal:  Trends Endocrinol Metab       Date:  2005 May-Jun       Impact factor: 12.015

Review 9.  Challenges in detecting the abuse of growth hormone in sport.

Authors:  Cathy M McHugh; Roderick T Park; Peter H Sönksen; Richard I G Holt
Journal:  Clin Chem       Date:  2005-07-14       Impact factor: 8.327

10.  Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting.

Authors:  Marie-Louise Healy; Rolf Dall; James Gibney; Eryl Bassett; Christer Ehrnborg; Claire Pentecost; Thord Rosen; Antonio Cittadini; Robert C Baxter; Peter H Sönksen
Journal:  J Clin Endocrinol Metab       Date:  2004-11-16       Impact factor: 5.958

View more
  1 in total

1.  Multiple protein biomarker assessment for recombinant bovine somatotropin (rbST) abuse in cattle.

Authors:  Susann K J Ludwig; Nathalie G E Smits; Grishja van der Veer; Maria G E G Bremer; Michel W F Nielen
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.